1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Michael K. Gibson: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| pBI-11 & TA-HPV (With Pembrolizumab as Treatment for Patients w/Advanced, PD-L1 CPS≥1, hrHPV+ Oropharyngeal Cancer DNA Vaccine, Human Papillomavirus Tumor Antigen Vaccine, Pembrolizumab - Metastatic Oropharyngeal Carcinoma, Recurrent Oropharyngeal Carcinoma | Phase 2 | Recruiting | Michael K. Gibson | 54 | 2023-07-26 | 2026-07-15 |
Biopsy (1) · Magnetic Resonance Spectroscopy (1) · Vaccines, DNA (1) · human papillomavirus vaccine, TA (1) · pembrolizumab (1)
United States (1)